Do Women with Pancreatic Cancer Have Higher Blood Sugar Levels?

Pancreatic cancer does not inherently cause higher blood glucose levels in women compared to men. Hyperglycemia—or elevated blood glucose—is a recognized paraneoplastic phenomenon associated with pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, but its occurrence is not sex-specific. Both men and women with newly diagnosed PDAC may present with new-onset diabetes mellitus or worsening glycemic control, often preceding clinical diagnosis by months to years.

This dysglycemia arises primarily from tumor-induced impairment of beta-cell function and insulin resistance, mediated by factors such as adrenomedullin, stromal-derived cytokines, and exocrine-endocrine crosstalk disruption—not hormonal differences between sexes. While epidemiologic studies show that women with pancreatic cancer are slightly less likely than men to develop new-onset diabetes, this difference is modest and not clinically predictive. Importantly, unexplained hyperglycemia in individuals over age 50—regardless of sex—warrants evaluation for underlying malignancy, including pancreatic cancer.

Clinicians should interpret elevated fasting glucose or HbA1c in the context of other red flags: unintentional weight loss, steatorrhea, jaundice, or abdominal pain. Screening for pancreatic cancer in asymptomatic individuals based solely on hyperglycemia is not recommended; however, persistent or progressive dysglycemia without clear etiology merits further investigation, particularly when accompanied by risk factors such as smoking, chronic pancreatitis, or familial pancreatic cancer syndromes.